Immediate Impact
5 by Nobel laureates 22 from Science/Nature 60 standout
Citing Papers
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
PARP and PARG inhibitors in cancer treatment
2020 Standout
Works of Thomas Rutherford being referenced
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG Oncology/Gynecologic Oncology Group study
2015
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Rutherford | 2273 | 1741 | 2340 | 2863 | 193 | 7.7k | |
| Adnan Munkarah | 1964 | 1736 | 1498 | 1906 | 180 | 6.1k | |
| Hani Gabra | 2167 | 946 | 2348 | 3199 | 174 | 7.2k | |
| Noriomi Matsumura | 1982 | 1172 | 3579 | 2405 | 209 | 7.6k | |
| Noriaki Sakuragi | 2498 | 3305 | 1262 | 2350 | 227 | 7.5k | |
| Toshiharu Kamura | 3005 | 2758 | 1494 | 2090 | 188 | 7.3k | |
| Alessandro D. Santin | 1937 | 1898 | 4452 | 3139 | 340 | 10.3k | |
| Aikou Okamoto | 1603 | 1058 | 1842 | 4363 | 258 | 7.8k | |
| Hal W. Hirte | 2230 | 572 | 3594 | 3170 | 154 | 7.9k | |
| Masaki Mandai | 2727 | 1652 | 4493 | 2822 | 333 | 10.3k | |
| Shashikant Lele | 1278 | 975 | 3306 | 2121 | 157 | 7.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...